Latest Industry Insights

In collaboration with UConn, Sensorion have identified the first potential biomarker for noise-induced hearing loss, findings which were recently presented at the 53rd American Neurotology Society Annual Spring Meeting.

To develop the best therapeutic mAb for treatment of a disease, hundreds of clones must be screened in downstream assays characterizing specificity, affinity, and binding kinetics. This article highlights ways to increase the throughput of purifying mAbs.

Whilst Mass Spectrometry is undoubted in its status as a central part of the proteomics toolkit, there is still debate about the way that MS data should be acquired and analyzed. Here, we talk to Florian Marty, Director Global Product Support at Biognosys AG, about why he believes that data-independent acquisition is a superior acquisition technique.

Research into major diseases is a time-critical field. Automation can help make research faster and more reproducible. In this blog, we discuss the advantages and challenges of incorporating automation into pathology with Coleman Stavish, Proscia Inc's Chief Technology Officer.

We recently spoke to Alice S. Chuck, Ph.D. Manufacturing Sciences & Technology Team Leader at Samsung BioLogics to learn more about the company and the completion of their newest facility, 'Songdo Plant No.3'. Alice discusses the key stages of biomanufacturing and highlights the importance of regulatory compliance.

Thermo Fisher Scientific’s Oncomine Dx Target Test, a cancer diagnostics panel, is set to be made available to 160 million people in the US through both Medicare and Medicaid and private insurers. We spoke with Joydeep Goswami, president of Clinical NGS and Oncology for Thermo Fisher Scientific, about the progress of NGS tests in the clinic.

In work published in the Journal of Experimental Biology, scientists from New Zealand and Japan tested two previously proposed theories of hair curvature using curly merino sheep wool.

We talked to Spencer Lamb, Verne Global’s Director of Research, to find out more about why Iceland could be a cheap, green solution for the data demands of modern research.

We catch up with Andrew James from Ellutia to discuss how and why their 200 Series GC is proving popular for testing potency, flavour profiling, and residual solvents.

Today’s chromatography lab needs to meet stringent regulations around data integrity; all analyses must be conducted with total transparency, and workflows must be robust and secure. Chromatography data systems (CDS) are incredibly effective at improving overall efficiencies and reducing user-error in the lab, but they can also advance compliance and data integrity.